ADPT

25.59

0.14% -0.035

Dopo l'orario di chiusura: 25.58 -0.005 -0.02%

Adaptive Biotechnologies Corp (ADPT)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Precedente Chiudi:

$25.62

Aprire:

$25.47

Volume 24 ore:

1.54M

Relative Volume:

0.62

Capitalizzazione di mercato:

$4.08B

Reddito:

$295.41M

Utile/perdita netta:

$-49.64M

Rapporto P/E:

-78.15

EPS:

-0.3274

Flusso di cassa netto:

$-29.54M

1 W Prestazione:

-1.94%

1M Prestazione:

-4.10%

6M Prestazione:

+76.08%

1 anno Prestazione:

+49.53%

Intervallo 1D:

$24.88

$25.91

Intervallo di 1 settimana:

$24.33

$26.85

Portata 52W:

$12.00

$30.74

Adaptive Biotechnologies Corp Stock (ADPT) Company Profile

Nome

Adaptive Biotechnologies Corp

Settore

Healthcare (1051)

Industria

Diagnostics & Research (44)

Telefono

206-659-0067

Indirizzo

1165 EASTLAKE AVE E, SEATTLE, WA

Dipendente

624

Cinguettio

@adaptivebiotech

Prossima data di guadagno

2026-11-04

Ultimi documenti SEC

ADPT's Discussions on Twitter

Compare ADPT vs TMO, DHR, NTRA, A, IQV

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
ADPT Adaptive Biotechnologies Corp	25.59	4.08B	295.41M	-49.64M	-29.54M	-0.3274
TMO Thermo Fisher Scientific Inc	696.57	257.55B	45.20B	6.87B	6.75B	18.19
DHR Danaher Corp	231.55	162.78B	24.78B	3.68B	5.29B	5.1743
NTRA Natera Inc	404.36	58.29B	2.50B	-226.32M	71.51M	-1.6412
A Agilent Technologies Inc	175.53	49.49B	7.23B	1.41B	1.09B	4.979
IQV Iqvia Holdings Inc	271.22	44.64B	16.63B	1.39B	2.12B	8.0674

Adaptive Biotechnologies Corp Stock (ADPT) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-12-02	Ripresa	Morgan Stanley	Equal-Weight
2025-09-30	Iniziato	Guggenheim	Buy
2025-06-18	Iniziato	Craig Hallum	Buy
2025-03-21	Aggiornamento	Goldman	Neutral → Buy
2023-07-05	Ripresa	JP Morgan	Overweight
2023-01-05	Iniziato	Scotiabank	Sector Outperform
2022-12-21	Aggiornamento	Piper Sandler	Neutral → Overweight
2022-08-25	Iniziato	Credit Suisse	Underperform
2022-06-03	Iniziato	Piper Sandler	Neutral
2022-02-16	Reiterato	BTIG Research	Buy
2022-02-16	Reiterato	BofA Securities	Buy
2022-02-16	Reiterato	Goldman	Neutral
2022-02-16	Reiterato	JP Morgan	Overweight
2021-10-15	Ripresa	Cowen	Outperform
2021-03-03	Downgrade	Goldman	Buy → Neutral
2020-10-08	Ripresa	BTIG Research	Buy
2020-09-09	Iniziato	Morgan Stanley	Equal-Weight
2020-06-03	Iniziato	Goldman	Buy
2019-07-23	Iniziato	BTIG Research	Buy
2019-07-22	Iniziato	BofA/Merrill	Buy
2019-07-22	Iniziato	Cowen	Outperform
2019-07-22	Iniziato	Goldman	Neutral
2019-07-22	Iniziato	Guggenheim	Buy
2019-07-22	Iniziato	William Blair	Outperform

Mostra tutto

Adaptive Biotechnologies Corp Borsa (ADPT) Ultime notizie

Oct 06, 2026

Adaptive Biotechnologies Officer Susan Bobulsky Files to Sell 6,444 Shares Under 10b5-1 Plan - Kalkine Media

Oct 06, 2026

Oct 05, 2026

Adaptive Biotechnologies COO Julie Rubinstein sells $1m in stock - Investing.com

Oct 05, 2026

Form 4 Adaptive Biotechnologies Corp For: 5 October By Investing.com - Investing.com Nigeria

Oct 05, 2026

An officer exercises options and sells Adaptive Biotechnologies (ADPT) shares under a preset plan. - Stock Titan

Oct 05, 2026

A COO exercises $12.14 options and sells 35,643 Adaptive Biotechnologies (ADPT) shares. - Stock Titan

Oct 05, 2026

Oct 01, 2026

Adaptive Biotechnologies Officer Julie Rubinstein Files Form 144 to Sell 379,777 Shares - Kalkine Media

Oct 01, 2026

Options exercised over three months will supply an officer's planned sale at Adaptive Biotechnologies (ADPT). - Stock Titan

Oct 01, 2026

Sep 28, 2026

Form 4 Adaptive Biotechnologies Corp For: 28 September By Investing.com - Investing.com Canada

Sep 28, 2026

Form 4 Adaptive Biotechnologies Corp For: 28 September By Investing.com - Investing.com South Africa

Sep 28, 2026

Sep 18, 2026

Adaptive Biotechnologies (ADPT) HR chief sells over 100,000 shares under preset plan - Stock Titan

Sep 18, 2026

Sep 17, 2026

Adaptive biotechnologies chief commercial officer sells $32,265 in shares. - Investing.com

Sep 17, 2026

Adaptive Biotechnologies (NASDAQ: ADPT) CCO sells shares under pre-set trading plan - Stock Titan

Sep 17, 2026

Sep 16, 2026

Adaptive Biotechnologies (ADPT) officer to sell 142K shares - Stock Titan

Sep 16, 2026

Sep 15, 2026

Officer at Adaptive Biotechnologies (NASDAQ: ADPT) plans sale of 1,195 shares - Stock Titan

Sep 15, 2026

Sep 02, 2026

Adaptive Biotechnologies (NASDAQ: ADPT) director reports stock gift, still holds 66,100 shares - Stock Titan

Sep 02, 2026